Functional and Neuroplastic Effects of HABIT-ILE in Children With Bilateral Cerebral Palsy
FuN HABIT-ILE
1 other identifier
interventional
48
1 country
1
Brief Summary
This randomized controlled trial will compare the effects of neuroplastic and functional changes of Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) when presented in two periods (2HG; n=24) versus a single period (1HG; n=24) in people with bilateral CP. The 1HG will receive 65 hours of HABIT-ILE over one intervention period; the 2HG will receive 130 hours over two intervention periods, within 6 months apart. Children will be assessed at 6 time points: baseline, three weeks after the start, at 3, 6, 7 and 9 months after the start of the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2024
CompletedFirst Posted
Study publicly available on registry
May 24, 2024
CompletedStudy Start
First participant enrolled
June 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
July 11, 2024
July 1, 2024
2.3 years
May 20, 2024
July 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Gross Motor Function
The Gross Motor Function Measure is a standardized observational instrument designed to measure changes in gross motor function over time or following an intervention in children and youth with cerebral palsy using Rasch analysis. It is scored on a scale of 0 to 3, where 0 means the person cannot perform the activity and 3 means the person can complete the item. The score is converted to a percentage. A higher percentage means a better gross motor function.
Baseline (T0), two weeks after start (T1), at 3 months (T2), at 6 months (T3), at 7 months (T4), and at 9 months (T5)
Secondary Outcomes (17)
Both Hands Assessment (BoHA)
Time Frame: Baseline (T0), two weeks after start (T1), at 3 months (T2), at 6 months (T3), at 7 months (T4), and at 9 months (T5)]
Melbourne 2 Assessment (MA2)
Time Frame: Baseline (T0), two weeks after start (T1), at 3 months (T2), at 6 months (T3), at 7 months (T4), and at 9 months (T5)]
Test of Arm Selective Control (TASC)
Time Frame: Baseline (T0), two weeks after start (T1), at 3 months (T2), at 6 months (T3), at 7 months (T4), and at 9 months (T5)
Selective Control Assessment of the Lower Extremity (SCALE)
Time Frame: Baseline (T0), two weeks after start (T1), at 3 months (T2), at 6 months (T3), at 7 months (T4), and at 9 months (T5)
Six minutes walk test (6MWT)
Time Frame: Baseline (T0), two weeks after start (T1), at 3 months (T2), at 6 months (T3), at 7 months (T4), and at 9 months (T5)
- +12 more secondary outcomes
Study Arms (2)
Double period
EXPERIMENTALSubjects will receive 130 hours of HABIT-ILE performed in two intervention periods as camp format for 6,5-hours/day, 5 days/week for two weeks. Each intervention period will be 6-months apart.
Single period
EXPERIMENTALSubjects will receive 65 hours of HABIT-ILE performed in one intervention period as camp format for 6,5-hours/day, 5 days/week for two weeks
Interventions
Structured bimanual tasks training, with gradual increase in motor difficulty, requiring increased postural adjustments and the use of the lower extremities.
Eligibility Criteria
You may qualify if:
- Children with medical diagnosis of bilateral cerebral palsy
- Cognitive capacity and language that allows understanding and following the therapist's instructions.
- Manual Ability Classification System (MACS) levels I to III
- Bimanual Fine Motor Function (BFMF) levels I to III
- Gross Motor Function Classification System (GMFCS) levels I to III
You may not qualify if:
- Severe visual problems
- Movement restriction due to orthopedic surgery in less than a year
- Treatment with botulinum toxin and/or baclofen pump in the last 6 months
- Contraindications to receive transcranial magnetic stimulation (epileptic history, metallic implants, neoplasm, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Exercise and Rehabilitation Sciences Institute, Universidad Nacional Andres Bello
Santiago, Santiago Metropolitan, 7591538, Chile
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rodrigo Araneda, PhD
Universidad Nacional Andres Bello
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 20, 2024
First Posted
May 24, 2024
Study Start
June 3, 2024
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
July 11, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share